The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells

Cancer Cell
H Daniel LacorazzaStephen D Nimer

Abstract

The transcriptional circuitry that regulates the quiescence of hematopoietic stem cells is largely unknown. We report that the transcription factor known as MEF (or ELF4), which is targeted by the t(X;21)(q26;q22) in acute myelogenous leukemia, regulates the proliferation of primitive hematopoietic progenitor cells at steady state, controlling their quiescence. Mef null HSCs display increased residence in G0 with reduced 5-bromodeoxyuridine incorporation in vivo and impaired cytokine-driven proliferation in vitro. Due to their increased HSC quiescence, Mef null mice are relatively resistant to the myelosuppressive effects of chemotherapy and radiation. Thus, MEF plays an important role in the decision of stem/primitive progenitor cells to divide or remain quiescent by regulating their entry to the cell cycle.

References

Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·M StewartJ C Neil
Jul 29, 1998·Journal of Korean Medical Science·C ChoiS W Juhng
Mar 10, 2000·Science·T ChengD T Scadden
Apr 17, 2002·Cell·Jennifer AntonchukR Keith Humphries
Aug 20, 2002·Nature Genetics·Takeshi SuzukiNeal G Copeland
Jul 5, 2003·Experimental Hematology·Julie Lessard, Guy Sauvageau
Sep 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emmanuelle PasseguéIrving L Weissman
Oct 24, 2003·Nature·L M CalviD T Scadden
Nov 26, 2003·Blood Cells, Molecules & Diseases·H Daniel Lacorazza, Stephen D Nimer
Dec 9, 2003·The Journal of Clinical Investigation·Myriam AlcalayPier Giuseppe Pelicci
Dec 19, 2003·Nucleic Acids Research·Keiko AkagiNeal G Copeland
Mar 17, 2004·Molecular and Cellular Biology·Carsten Müller-TidowHubert Serve
Oct 6, 2005·Blood·Fernando D CamargoMargaret A Goodell
Dec 7, 2005·The Journal of Experimental Medicine·Emmanuelle PasseguéIrving L Weissman

❮ Previous
Next ❯

Citations

Jun 15, 2011·International Journal of Hematology·Zhenyu JuTao Cheng
Jan 9, 2009·Cell Stem Cell·Ronald van OsBrad J Dykstra
Nov 16, 2010·Nature Cell Biology·Olga SirinMargaret A Goodell
Nov 30, 2007·Gene Therapy·T Cheng
May 14, 2008·The Journal of Experimental Medicine·Benjamin J ThompsonIannis Aifantis
Sep 2, 2010·Nucleic Acids Research·Manabu TauraHirofumi Kai
Jun 24, 2010·Current Opinion in Hematology·James D PhelanH Leighton Grimes
Apr 22, 2009·Molecular and Cellular Biology·Goro SashidaStephen D Nimer
May 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ling Li, Ravi Bhatia
Feb 26, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Mariela SivinaH Daniel Lacorazza
Feb 23, 2008·The Journal of Clinical Investigation·Fulu LiuDaniel C Link
Jan 24, 2012·Blood·Chia-Jui KuJames Douglas Engel
May 27, 2010·BMC Genomics·Maria Ana DuhagonWilliam L Farrar
Jun 14, 2012·PloS One·Takeshi YamadaH Daniel Lacorazza
Apr 21, 2012·Future Oncology·Runhua LiuLizhong Wang
Mar 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Michelle B BowieConnie J Eaves
Sep 18, 2013·Blood Cells, Molecules & Diseases·Cary N Weiss, Keisuke Ito
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Linda YangYi Zheng
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Vladimir JankovicStephen D Nimer
Jun 7, 2014·Interface Focus·Guang Yao
May 28, 2011·Cancer Research·Goro SashidaStephen D Nimer
Oct 9, 2013·Molecular and Cellular Biology·Ling YanRizwan Hamid
Apr 22, 2015·Seminars in Cancer Biology·Mark A FeitelsonSomaira Nowsheen
Dec 15, 2015·International Journal of Hematology·Zhao Wang, Hideo Ema
Mar 18, 2008·Best Practice & Research. Clinical Haematology·Stephen D Nimer
Jul 22, 2008·Journal of Anatomy·Robert K Montgomery, David T Breault
Jun 11, 2011·Journal of Cellular Physiology·Takashi AsaiStephen D Nimer
Sep 3, 2009·Journal of Cellular Physiology·Pernilla Eliasson, Jan-Ingvar Jönsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.